The World Gold Council said global demand for gold accelerated in the third quarter as investors sought safe-haven assets due to growing geopolitical uncertainty and a weaker U.S. dollar.
OneMain Holdings has been in business for over a hundred years, weathered several poor markets, reliably pays a 7% dividend, and trades at a forward PE of around 9. The company still looks this attractive, partially because of the perceived competition by a host of FinTech companies competing for loan origination. Yet, several of these FinTechs, many of which promote their AI-risk differentiation, operate largely unproven models in what looks to be a more uncertain macro environment.
Tesla will debut its Cybercab at the China International Import Expo in Shanghai which runs November 5-10, an executive at the car maker said on social media on Thursday.
Spain's BBVA on Thursday said its third-quarter net profit fell 3.7% compared to the same period in 2024 as higher lending income was offset by the depreciation of currencies in South America and Mexico.
Range Resources Corporation ( RRC ) Q3 2025 Earnings Call October 29, 2025 9:00 AM EDT Company Participants Laith Sando - Senior Vice President of Corporate Strategy & Investor Relations Dennis Degner - CEO, President & Director Mark Scucchi - Executive VP & CFO Alan Engberg Conference Call Participants Jacob Roberts - Tudor, Pickering, Holt & Co. Securities, LLC, Research Division Kaleinoheaokealaula Akamine - BofA Securities, Research Division Michael Scialla - Stephens Inc., Research Division Arun Jayaram - JPMorgan Chase & Co, Research Division Douglas George Blyth Leggate - Wolfe Research, LLC Paul Diamond - Citigroup Inc., Research Division Margaret Drefke - Goldman Sachs Group, Inc., Research Division David Deckelbaum - TD Cowen, Research Division Presentation Operator Good day. Welcome to the Range Resources Third Quarter 2025 Earnings Conference Call.
BRUSSELS--(BUSINESS WIRE)--Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): Regulated and inside information1 “Driven by the momentum of our megabrands and our innovation in balanced choices and Beyond Beer, our business delivered continued top- and bottom-line growth, even as we navigated a dynamic consumer environment. Given the progress we have made on our deleveraging and solid year-to-date financial results we have announced a new 6 billion USD share buyback program and a.
France's Credit Agricole SA said on Thursday its third-quarter profit rose 10%, beating expectations but only after it marked up the value of its increased stake in Italy's Banco BPM and investment banking revenues rose.
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR THIRD QUARTER/NINE MONTHS | 2025 Q3 2025 sales decreased by 3 % in local currencies 1 to CHF 906 million, as modest growth in Adsorbents & Additives was offset by lower sales in Care Chemicals and Catalysts Q3 2025 EBITDA margin before exceptional items increased by 230 basis points to 17.9 % from 15.6 % in Q3 2024, driven by performance improvement programs and price and cost management in all businesses 9M 2025 sales decreased by 1 % in local currencies 1 to CHF 2.887 billion, driven by lower volumes 9M 2025 EBITDA margin before exceptional items increased by 160 basis points to 18.0 % from 16.4 % in the prior year due to performance improvement programs and price and cost management Investor Day savings program of CHF 80 million is on track with CHF 31 million savings achieved year-to-date Outlook 2025 confirmed: local currency sales growth expected at the lower end of the 1 – 3 % range and EBITDA margin before exceptional items of between 17 – 18 % “We achieved significant growth in profitability in the third quarter of 2025, showcasing the success of our performance improvement programs and effective price and cost management across our business units.
Basel, 30 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche's wholly owned subsidiary Bluefin Merger Subsidiary, Inc., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of 89bio, Inc. (“89bio”, NASDAQ: ETNB) at a price of $14.50 per share in cash, plus a non-tradeable contingent value right (CVR) to receive certain milestone payments of up to an aggregate of $6.00 per share in cash. The tender offer expired at one minute following 11:59 p.m., New York City time, on October 29, 2025, and was not extended.
$1.13 billion in third quarter global product net sales On track to submit seronegative gMG sBLA by year-end and report ADAPT-OCULUS results in 1H26 – supporting pursuit of broadest MG label of any biologic Five registrational study readouts expected in 2026 from leading immunology pipeline Management to host conference call today at 1:30 PM CET (8:30 AM ET) October 30, 2025 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its third quarter 2025 financial results and provided a business update. “argenx continues to deliver on our bold innovation agenda, driving transformational impact for patients worldwide,” said Tim Van Hauwermeiren, Chief Executive Officer of argenx.
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS.
Press Release Kaiseraugst (Switzerland), Maastricht (Netherlands), October 30, 2025 dsm-firmenich Q3 2025 trading update Management Report Q3 2025 highlights Solid growth and strong step up in Adjusted EBITDA on a comparable basis1 Advancing well on 2025 strategic plan Animal Nutrition & Health (‘ANH') exit process ongoing FY 2025 outlook updated for foreign exchange and ANH-related vitamin volatility: Adjusted EBITDA of around €2.3 billion Key figures in € millions Q3 YTD 2025 Q3 YTD 2024 % Change Q3 2025 Q3 2024 % Change Sales 9,580 9,542 0 3,070 3,244 (5) Organic sales growth (%) 5 2 Adj. EBITDA 1,800 1,517 19 540 541 (0) Adj.
Fornebu, Norway - 30 October 2025 – Amid rising geopolitical tensions and increasingly sophisticated digital threats, Telenor today releases its annual Nordic security report, calling for a stronger and more coordinated regional approach to security and preparedness. The report highlights the growing interdependence of critical services such as power and digital infrastructure and calls on governments and industry to act jointly to build greater Nordic resilience that protects societies, economies, and people.
Ad hoc announcement pursuant to Art. 53 LR QUVIVIQ (daridorexant) global net sales (excluding sales to partners) increased by >130% year-on-year to CHF 91 million in 9M 2025 – continuing Idorsia's trajectory towards profitability Aprocitentan (TRYVIO/JERAYGO) the first and only dual ERA indicated for systemic hypertension and the only new medicine to be included in the ACC/AHA Hypertension Management guidelines Operating cash runway extended beyond profitability into 2028 following CHF 65.6 million financing with oversubscribed demand from top-tier US and European institutional investors Allschwil, Switzerland – October 30, 2025 Idorsia Ltd (SIX: IDIA), announces 9-month 2025 financial results.
Hyundai Motor posted weaker earnings in the third quarter, dented by U.S. tariffs, but some relief is on the horizon.
Guardant Health, Inc. ( GH ) Q3 2025 Earnings Call October 29, 2025 4:30 PM EDT Company Participants Zarak Khurshid - Vice President of Investor Relations Helmy Eltoukhy - Co-Founder, Co-CEO & Chairman AmirAli Talasaz - Co-CEO & Director Michael Bell - Chief Financial Officer Conference Call Participants Bradley Bowers - Mizuho Securities USA LLC, Research Division Douglas Schenkel - Wolfe Research, LLC Puneet Souda - Leerink Partners LLC, Research Division Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division Patrick Donnelly - Citigroup Inc., Research Division Tycho Peterson - Jefferies LLC, Research Division William Bonello - Craig-Hallum Capital Group LLC, Research Division Mark Massaro - BTIG, LLC, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Kyle Mikson - Canaccord Genuity Corp., Research Division Luke Sergott - Barclays Bank PLC, Research Division Daniel Brennan - TD Cowen, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Good afternoon. Thank you for attending the Guardant Health Q3 2025 Earnings Call.
SK Telecom Co., Ltd. ( SKM ) Q3 2025 Earnings Call October 29, 2025 9:00 PM EDT Company Participants Jun Chung Hee - VP & Head of IR Yang-Seob Kim - CFO, Head of Corporate Planning Center & Executive Director Ji Hoon Kim - Head of AI Business Strategy Office Conference Call Participants Jae-min Ahn - NH Investment & Securities Co., Ltd.
Resideo Technologies (REZI), Inc. was the top contributor in the quarter driven by strong earnings and a subsequent raise in guidance. Sphere Entertainment (SPHR) Co. also advanced over the period, supported by strengthening business fundamentals and demand for The Wizard of Oz. KN remains well-positioned to benefit from its focus on niche, market-leading positions in hearing health and precision devices.
Magnolia Group bought 44,500 shares of Asbury Automotive with an estimated transaction value of $10.82 million based on the stock's quarterly average price. Magnolia Group's purchase represents a 1.71% increase relative to the fund's 13F reportable assets under management.
Lynas Rare Earths, an Australian company, announced on Thursday a 66% increase in its first-quarter revenue compared to the previous year. Despite this growth, the results did not meet market expectations.